These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 38062011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
    Ma Y, Zhang H, Chen C, Liu L, Ding T, Wang Y, Ma D, Ling X, Chen X, Li J, Guansheng, Zhong, Ru G, Zhang L, Tang J.
    Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
    [Abstract] [Full Text] [Related]

  • 3. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Lu L, Dong J, Wang L, Xia Q, Zhang D, Kim H, Yin T, Fan S, Shen Q.
    Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
    [Abstract] [Full Text] [Related]

  • 4. DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1.
    Mitchell AV, Wu J, Meng F, Dong L, Block CJ, Song WM, Zhang B, Li J, Wu G.
    Cancer Res Commun; 2022 Nov; 2(11):1388-1403. PubMed ID: 36713812
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M, Li AQ, Zhou SL, Lv H, Wei P, Yang WT.
    J Exp Clin Cancer Res; 2020 May 24; 39(1):92. PubMed ID: 32448269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer.
    Gong C, Zou J, Zhang M, Zhang J, Xu S, Zhu S, Yang M, Li D, Wang Y, Shi J, Li Y.
    Mol Carcinog; 2019 Oct 24; 58(10):1863-1875. PubMed ID: 31264274
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
    Zhang J, Liu Y, Zhang J, Cui X, Li G, Wang J, Ren H, Zhang Y.
    Oncol Rep; 2016 Jun 24; 35(6):3607-13. PubMed ID: 27109028
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer.
    Su YH, Wu YZ, Ann DK, Chen JL, Kuo CY.
    Cell Death Dis; 2023 Jan 21; 14(1):53. PubMed ID: 36681663
    [Abstract] [Full Text] [Related]

  • 17. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
    Peng X, Luo Z, Kang Q, Deng D, Wang Q, Peng H, Wang S, Wei Z.
    Cancer Biol Ther; 2015 Jan 21; 16(7):1099-109. PubMed ID: 25955104
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, Chen J.
    Phytomedicine; 2023 Sep 21; 118():154924. PubMed ID: 37393829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.